Jeremy Hsu is a science and technology journalist who writes for publications such as Scientific American, Discover, Wired, IEEE Spectrum and Undark. His recent focus has been on how artificial intelligence techniques such as deep learning could impact society.
Jeremy Hsu
From this contributor
How scientists secure the data driving autism research
Protecting the privacy of autistic people and their families faces new challenges in the era of big data.
How scientists secure the data driving autism research
By
Jeremy Hsu
30 September 2020 | 16 min read
Un ordinateur peut-il diagnostiquer l’autisme?
L’apprentissage automatique (machine learning) présente une possibilité pour aider les cliniciens à repérer l'autisme plus tôt, mais des obstacles techniques et éthiques demeurent.
Why are there so few autism specialists?
A lack of interest, training and pay may limit the supply of specialists best equipped to diagnose and treat children with autism.
Can a computer diagnose autism?
Machine-learning holds the promise to help clinicians spot autism sooner, but technical and ethical obstacles remain.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read